Source:http://linkedlifedata.com/resource/pubmed/id/17558744
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3-4
|
| pubmed:dateCreated |
2007-6-11
|
| pubmed:abstractText |
Tumors aberrantly express tumor-associated antigens that can be specifically recognized by T-cells, thereby providing a scientific rationale for the design and clinical testing of immunotherapeutic strategies targeting these antigens. Multiple myeloma is a fatal hematologic malignancy. Here, we review techniques to discover new tumor-associated antigens in multiple myeloma and the latest immunotherapeutic strategies employed in this disease.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0883-0185
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
197-222
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:17558744-Animals,
pubmed-meshheading:17558744-Antigens, Neoplasm,
pubmed-meshheading:17558744-Clinical Trials as Topic,
pubmed-meshheading:17558744-Disease Models, Animal,
pubmed-meshheading:17558744-Humans,
pubmed-meshheading:17558744-Immunotherapy,
pubmed-meshheading:17558744-Melanoma-Specific Antigens,
pubmed-meshheading:17558744-Multiple Myeloma,
pubmed-meshheading:17558744-Neoplasm Proteins
|
| pubmed:articleTitle |
Advances in immunotherapy of multiple myeloma: from the discovery of tumor-associated antigens to clinical trials.
|
| pubmed:affiliation |
Department of Microbiology and Immunology and Division of Hematology/Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, Texas 79430, USA. maurizio.chiriva@ttuhsc.edu
|
| pubmed:publicationType |
Journal Article,
Review
|